CAROLINE PEEPLES: Open Payments
NPI 1598328684 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 20 payments from 12 companies in 2025. Trend: 2023 $526 · 2024 $320 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC | 4 | $69 |
| Exeltis, USA Inc. | 3 | $53 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Organon LLC | 2 | $31 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: SLYND, NOVASURE, ZEPBOUND, NEXPLANON, ACCRUFER, Lynkuet, TRINTELLIX, Dexcom G6 Transmitter.
Industry payments across MS — which companies pay providers there.
